KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication

Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi’s sarcoma, primary effusion lymphoma and multicentric Castleman’s disease. Since the discovery of KSHV 20 years ago, there is still no standard treatment and the management of virus-associated malignancies remains toxic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Natacha Coen, Sophie Duraffour, Robert Snoeck, Graciela Andrei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI AG 2014-11-01
Seri Bilgileri:Viruses
Konular:
KSHV
antiviral
nucleoside analog
DNA polymerase inhibitors
lytic cycle
ganciclovir
cidofovir
foscarnet
Online Erişim:http://www.mdpi.com/1999-4915/6/11/4731
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller